| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2007-05-22 17:55:08 UTC |
|---|
| Update Date | 2022-03-07 02:49:30 UTC |
|---|
| HMDB ID | HMDB0006219 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | 13-cis-Retinoic acid |
|---|
| Description | 13-cis-Retinoic acid is a topical dermatologic agent that is used in the treatment of acne vulgaris and several other skin diseases. The drug has teratogenic and other adverse effects (PubChem). 13-cis-Retinoic acid is also a naturally occurring retinoid that is present in the circulation. Although 13-cis-retinoic acid (isotretinoin) does not have the potent gene regulatory activity of other isomers, it is an effective pharmacologic agent for treating a variety of dermatologic conditions (PMID:11606944 ). The steric conversion of 13-cis-retinoic acid (13-cRA) to all-trans-retinoic acid (t-RA) has been proposed as an activation mechanism for the observed therapeutic and teratogenic activities of 13-cRA (PMID:9806904 ). 13-cis Retinoic acid exerts its specific activity on human sebocytes through selective intracellular isomerization to all-trans retinoic acid and binding to retinoid acid receptors (PMID:10951254 ). |
|---|
| Structure | C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- |
|---|
| Synonyms | | Value | Source |
|---|
| (7E,9E,11E,13Z)-Retinoic acid | ChEBI | | 13-cis-Vitamin a acid | ChEBI | | 13-RA | ChEBI | | Accutane | ChEBI | | Amnesteem | ChEBI | | cis-RA | ChEBI | | Claravis | ChEBI | | Isotretinoina | ChEBI | | Isotretinoine | ChEBI | | Isotretinoino | ChEBI | | Isotretinoinum | ChEBI | | Neovitamin a acid | ChEBI | | Absorica | Kegg | | Sotret | Kegg | | (7E,9E,11E,13Z)-Retinoate | Generator | | 13-cis-Retinoate | Generator | | (13-cis)-Retinoate | HMDB | | (13-cis)-Retinoic acid | HMDB | | CIP-isotretinoin | HMDB | | cis-Retinoate | HMDB | | cis-Retinoic acid | HMDB | | Isotretinoin | HMDB | | Isotrex | HMDB | | Retinoate | HMDB | | Retinoic acid | HMDB | | Roaccutan | HMDB | | Roaccutane | HMDB | | Roacutan | HMDB | | Teriosal | HMDB | | Isotretinoin zinc salt, 13 cis isomer | HMDB | | Isotretinoin zinc salt, 13-cis-isomer | HMDB | | 13 cis Retinoic acid | HMDB | | 13-cis-Retinoate,isotretinoin | HMDB | | 13-cis-Retinoic acid | ChEBI |
|
|---|
| Chemical Formula | C20H28O2 |
|---|
| Average Molecular Weight | 300.4351 |
|---|
| Monoisotopic Molecular Weight | 300.20893014 |
|---|
| IUPAC Name | (2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenoic acid |
|---|
| Traditional Name | isotretinoin |
|---|
| CAS Registry Number | 4759-48-2 |
|---|
| SMILES | C\C(\C=C\C1=C(C)CCCC1(C)C)=C/C=C/C(/C)=C\C(O)=O |
|---|
| InChI Identifier | InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14- |
|---|
| InChI Key | SHGAZHPCJJPHSC-XFYACQKRSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as retinoids. These are oxygenated derivatives of 3,7-dimethyl-1-(2,6,6-trimethylcyclohex-1-enyl)nona-1,3,5,7-tetraene and derivatives thereof. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Prenol lipids |
|---|
| Sub Class | Retinoids |
|---|
| Direct Parent | Retinoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Retinoic acid
- Diterpenoid
- Retinoid skeleton
- Medium-chain fatty acid
- Branched fatty acid
- Methyl-branched fatty acid
- Fatty acyl
- Unsaturated fatty acid
- Fatty acid
- Monocarboxylic acid or derivatives
- Carboxylic acid
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organooxygen compound
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Aliphatic homomonocyclic compound
|
|---|
| Molecular Framework | Aliphatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 8.33 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 25.9971 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.19 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 3405.6 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 798.4 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 300.1 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 502.7 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 379.8 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1030.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 960.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 99.1 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 2162.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 747.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1810.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 825.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 576.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 507.5 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 760.6 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 8.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 13-cis-Retinoic acid GC-MS (Non-derivatized) - 70eV, Positive | splash10-052r-2090000000-42b8aa0666b5a088671b | 2017-08-28 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 13-cis-Retinoic acid GC-MS (1 TMS) - 70eV, Positive | splash10-0a4i-5139000000-29caedb85908ca2b99f4 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 13-cis-Retinoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 13-cis-Retinoic acid GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - 13-cis-Retinoic acid Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0udi-0009000000-12dbd83959268dee6dbf | 2012-07-25 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 13-cis-Retinoic acid Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-066r-4900000000-31c9262cbbf0bad5b738 | 2012-07-25 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - 13-cis-Retinoic acid Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-0fsl-9600000000-c6681587f0a9ae7a712e | 2012-07-25 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 10V, Positive-QTOF | splash10-0uei-0494000000-28e6366fdd47e8ba2117 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 20V, Positive-QTOF | splash10-052r-2980000000-3e7fc78de83c23830416 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 40V, Positive-QTOF | splash10-052r-5900000000-ef4d86f8bcf86959f794 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 10V, Negative-QTOF | splash10-052b-0090000000-e07ffb4c1e5c63ab1b59 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 20V, Negative-QTOF | splash10-052b-0090000000-a0a8411213bbd2543243 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 40V, Negative-QTOF | splash10-000i-3690000000-97e6a74798dd69c30ad1 | 2017-07-26 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 10V, Positive-QTOF | splash10-0zir-0973000000-3040e9e4a1a5448efbcb | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 20V, Positive-QTOF | splash10-060c-1950000000-f3b9c9b378f60b8c49a9 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 40V, Positive-QTOF | splash10-0ar3-5910000000-de22eb65f274483f3f98 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 10V, Negative-QTOF | splash10-052b-0090000000-5f942e3b870e7bd0121b | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 20V, Negative-QTOF | splash10-0a4i-0190000000-22b445382d3977280045 | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 13-cis-Retinoic acid 40V, Negative-QTOF | splash10-016r-4900000000-0005b37f6d54a42a84f6 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR Spectra| Spectrum Type | Description | Deposition Date | Source | View |
|---|
| Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, CDCl3, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
|---|